HER2 positive subtypes of breast cancer are negative in terms of ER and PR receptors expression and are positive for HER2 expression (ER–/PR–/HER2+) and express markers such as CK5, CK8, CK18, and CK19 [7–9]. This evidence concerns the gene ERBB2 and breast carcinoma.